Abstract
The coronavirus disease 2019 (COVID-19) is a viral infection caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has emerged as a global pandemic leading to a massive loss of human life worldwide due to its high transmissibility.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
SARS-CoV-2 variants of concern and variants under investigation in England. Technical briefing 31. December 10, 2021. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1040076/Technical_Briefing_31.pdf. Accessed on December 13, 2021.
SARS-CoV-2 variants of concern and variants under investigation. 33.
Li D, Jin M, Bao P, Zhao W, Zhang S. Clinical characteristics and results of semen tests among men with coronavirus disease 2019. JAMA Netw Open. 2020;3:e208292.
CDC. Quarantine & isolation [Internet]. Centers for disease control and prevention 2022 [cited 2022 Apr 15]; Available from: https://www.cdc.gov/coronavirus/2019-ncov/your-health/quarantine-isolation.html
Ma Q, Liu J, Liu Q, Kang L, Liu R, Jing W, et al. Global percentage of asymptomatic SARS-CoV-2 infections among the tested population and individuals with confirmed COVID-19 diagnosis: a systematic review and meta-analysis. JAMA Netw Open. 2021;4:e2137257.
CDC. Healthcare Workers [Internet]. Centers for disease control and prevention 2020 [cited 2022 Apr 15]; Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html
Clinical features of covid-19 | The BMJ [Internet]. [cited 2022 Apr 15]; Available from: https://www.bmj.com/content/369/bmj.m1470/rapid-responses
Serum troponin, D-dimer, and CRP level in severe coronavirus (COVID-19) patients–PubMed [Internet]. [cited 2022 Apr 15]; Available from: https://pubmed.ncbi.nlm.nih.gov/34939346/
Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S, et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2020;8:CD013705.
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab | NEJM [Internet]. [cited 2022 Apr 15]; Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2107934
CDC. Cases, Data, and Surveillance [Internet]. Centers for Disease Control and Prevention 2020 [cited 2022 May 25]; Available from: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/assessing-risk-factors.html
Concomitant Medications [Internet]. COVID-19 Treatment Guidelines [cited 2022 Apr 20]; Available from: https://www.covid19treatmentguidelines.nih.gov/therapies/concomitant-medications/
Marshall JC, Murthy S, Diaz J, Adhikari NK, Angus DC, Arabi YM, et al. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20:e192–7.
Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601–15.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Moorjani, H., Gupta, S.K. (2022). COVID-19: An Overview. In: Mohan, A., Mittal, S. (eds) Post COVID-19 Complications and Management. Springer, Singapore. https://doi.org/10.1007/978-981-19-4407-9_1
Download citation
DOI: https://doi.org/10.1007/978-981-19-4407-9_1
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-4406-2
Online ISBN: 978-981-19-4407-9
eBook Packages: MedicineMedicine (R0)